Electra Therapeutics

Recent Finacing

Series C

Recent Raise

$183M

Electra Therapeutics is a late-stage US biotechnology company developing precision antibody medicines that selectively target overactive immune cells implicated in serious immunological and cancer-related diseases.

California, United States

11-50

Private

electra-therapeutics.com

Highlights

Focus Areas

Biotechnology

Health Care

Medical

Recent Investors

Financials

$267M

Total Raised

2

Funding rounds

12

Investors

Team

Upgrade to view the team

See the team members at Electra Therapeutics.